| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 02/17/2010 | EP2153832A2 Heterocyclic aspartyl protease inhibitors |
| 02/17/2010 | EP2152699A1 Quinolone compound and pharmaceutical composition |
| 02/17/2010 | CN101648948A Medicine of 3-alkoxyl-mangiferin for lowering blood pressure, synthesis and application |
| 02/16/2010 | US7662977 Such as 2-cationic amino-4-oxo-chromene derivatives; water solubility, pharmacokinetics; reduced side effects; anticancer agents |
| 02/16/2010 | US7662824 (S)-4-Bromo-3-[(2-2,3-dihydro-benzofuran-5-yl-acetyl)-hydrazono]-2-oxo-2,3-dihydro-1H-indole-6-carboxylic acid [3-(2-hydroxymethyl-pyrrolidin-1-yl)-propyl]-amide; for treating conditions such as cancers and other cell proliferative disorders |
| 02/16/2010 | CA2450922C Piperidines for use as orexin receptor antagonists |
| 02/11/2010 | WO2010017350A1 Aminopyridine kinase inhibitors |
| 02/11/2010 | WO2010015211A1 Synthesis of oxazoline compounds |
| 02/11/2010 | DE112007003449T5 3,4-Dicarboxy-1,2,3,4-Tetrahydro-6-t-Butyl-1-Naphtalinbernsteinsäuredianhydrid und Flüssigkristallausrichtungsmittel, das aus dem Dianhydrid hergestelltes Polymidharz umfasst 3,4-dicarboxy-1,2,3,4-tetrahydro-6-t-butyl-1-Naphtalinbernsteinsäuredianhydrid and liquid crystal alignment agent prepared from the dianhydride polyimide resin comprises |
| 02/11/2010 | CA2732765A1 Aminopyridine kinase inhibitors |
| 02/10/2010 | EP2150265A1 Inhibitors of acetyl-coa carboxylase for treatment of neuronal hypometabolism |
| 02/09/2010 | US7659413 (Meth) acryloyl group-containing oxetane compound and production method thereof |
| 02/04/2010 | US20100028461 Gamma-butyrolactone compound and pharmaceutical composition thereof |
| 02/03/2010 | CN100586947C Compound with antineoplastic activity, production method and application thereof |
| 02/02/2010 | US7655621 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/02/2010 | US7655442 Method for stabilizing macrolide compounds |
| 02/02/2010 | CA2578722C Process for atorvastatin calcium amorphous |
| 01/28/2010 | WO2010011626A2 Pyridinyl modulators of ϒ-secretase |
| 01/28/2010 | WO2010010154A1 3,4-diarylpyrazoles as protein kinase inhibitors |
| 01/28/2010 | WO2009077497A3 Azolyl methyl oxiranes, the use thereof, and agents containing them |
| 01/28/2010 | WO2008137816A8 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 01/28/2010 | CA2731190A1 Pyridinyl modulators of .gamma.-secretase |
| 01/28/2010 | CA2731146A1 3,4-diarylpyrazoles as protein kinase inhibitors |
| 01/26/2010 | US7652060 Small molecule rotamase enzyme inhibitors |
| 01/26/2010 | US7652031 Compounds which mimic the chemical and biological properties of discodermolide |
| 01/21/2010 | WO2010009166A1 Oxindolyl inhibitor compounds |
| 01/21/2010 | WO2010009069A1 Chromene modulators of chemokine receptor activity |
| 01/21/2010 | US20100016327 Quinoline compounds |
| 01/21/2010 | CA2728228A1 Oxindolyl inhibitor compounds |
| 01/20/2010 | EP2144899A1 Epoxy compound and method for manufacturing the same |
| 01/20/2010 | EP2144893A2 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 01/20/2010 | EP1663211B1 Aminotriazole compounds useful as inhibitors of protein kinases |
| 01/20/2010 | EP1654247B1 Alkynyl aryl carboxamides |
| 01/20/2010 | EP1095938B1 Oxetane compounds, oxetane copolymer, and process for producing oxetane compounds |
| 01/19/2010 | US7649080 Reacting vancomycin with a coupling reagent, then reacting with a cephalosporin derivative; making antibiotic effective against antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococci aureus (MRSA) |
| 01/14/2010 | WO2010005783A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors |
| 01/14/2010 | WO2010004198A2 Antineoplastic derivatives, preparation thereof, and therapeutic use thereof |
| 01/14/2010 | US20100010013 Dihydropyrimidine compounds and their uses in manufacture of a medicament for treatment and prevention of viral diseases |
| 01/14/2010 | CA2730116A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors |
| 01/14/2010 | CA2730071A1 Antineoplastic derivatives of 4-oxo-l, 4-dihydro-quinolin?, preparation thereof, and therapeutic use thereof |
| 01/12/2010 | US7645888 Process for the production of amorphous atorvastatin calcium |
| 01/12/2010 | CA2560489C Pyranone compounds useful to treat retroviral infections |
| 01/07/2010 | WO2010002483A1 Optionally condensed dihydro pyridine, dihydropyrimidine and dihydro pyrane derivatives acting as late sodium channel blockers |
| 01/07/2010 | WO2010000193A1 Preparation of osemozotan and its pharmaceutically acceptable salts, and its intermediate |
| 01/07/2010 | WO2009124723A3 Novel aureothin derivatives |
| 01/05/2010 | US7642254 ATM inhibitors |
| 12/31/2009 | US20090323011 Mesogen containing compounds |
| 12/30/2009 | WO2009158571A1 Heteroaryl compounds and uses thereof |
| 12/30/2009 | WO2009158467A2 Di-substituted phenyl compounds |
| 12/30/2009 | WO2009158426A1 6-substituted phenoxychroman carboxylic acid derivatives |
| 12/30/2009 | WO2009158381A1 Novel psymberin derivatives, compositions, and their use as antineoplastic agents |
| 12/30/2009 | WO2009158011A1 Alkynyl alcohols as kinase inhibitors |
| 12/30/2009 | WO2009155887A1 Composition of flavanolignan and amino acid with improved water solubility |
| 12/30/2009 | WO2009155786A1 Amine compounds and their pharmaceutical use |
| 12/30/2009 | WO2009136995A3 2, 6-diamino- pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors |
| 12/30/2009 | WO2008141234A3 Methods of making epothilones |
| 12/30/2009 | EP1490047B1 Certain pharmaceutically useful substituted aminoalkyl heterocycles |
| 12/30/2009 | CN101616912A Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the same |
| 12/30/2009 | CN101613346A Preparation method of silibinin ether substituted by A ring and medical application thereof |
| 12/30/2009 | CN101613345A Preparation method of silibinin ether substituted by diolefin propyl and medical application thereof |
| 12/30/2009 | CA2729220A1 Di-substituted phenyl compounds |
| 12/30/2009 | CA2729217A1 6-substituted phenoxychroman carboxylic acid derivatives |
| 12/30/2009 | CA2728767A1 Alkynyl alcohols as kinase inhibitors |
| 12/30/2009 | CA2727455A1 Heteroaryl compounds and uses thereof |
| 12/30/2009 | CA2727197A1 Composition of flavanolignan and amino acid with improved water solubility |
| 12/29/2009 | US7638540 Benzofuran compound and medicinal composition containing the same |
| 12/29/2009 | CA2370250C Di-aryl acid derivatives as ppar receptor ligands |
| 12/29/2009 | CA2287214C Substituted benzopyran derivatives for the treatment of inflammation |
| 12/23/2009 | WO2009155042A1 3-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 12/23/2009 | WO2009152995A1 Substituted 1-(diazinyl) pyrazole-4-yl-acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators |
| 12/23/2009 | WO2009152824A1 Heterocyclic derivatives as iap binding compounds |
| 12/23/2009 | EP2135865A1 Substituted 1-(diazinyl)pyrazol-4-yl acetic acids, method for their production and their use as herbicides and plant growth regulators |
| 12/23/2009 | EP2134686A1 Piperidinones useful in the treatment of inflammation |
| 12/23/2009 | EP2134683A2 Novel inhibitors hepatitis c virus replication |
| 12/23/2009 | CN101611031A 3,4-dicarboxy-1,2,3,4-tetrahydro-6-t-butyl-1-naphthalene succinic dianhydride and liquid crystal aligning agent comprising polyimide resin prepared from the dianhydride |
| 12/23/2009 | CN101611018A Heterocyclyc sulfonamides having Edg-I antagonistic activity |
| 12/23/2009 | CN100572364C HIV replication inhibiting pyrimidines and triazines |
| 12/23/2009 | CA2728476A1 Heterocyclic compound and use thereof |
| 12/23/2009 | CA2728205A1 Substituted 1-(diazinyl)pyrazole-4-yl-acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators |
| 12/23/2009 | CA2723279A1 3-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 12/17/2009 | WO2009150095A1 Pesticidal compositions containing a pyrandione or a thiopyrandione or a cyclohexanetrione derivative |
| 12/17/2009 | WO2009150094A1 Novel herbicides |
| 12/17/2009 | WO2009150093A1 Novel herbicides |
| 12/17/2009 | US20090312543 Pyrazole compounds useful as protein kinase inhibitors |
| 12/17/2009 | US20090312339 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group |
| 12/17/2009 | US20090309076 Photochromic compounds |
| 12/16/2009 | EP2132191A2 Method for manufacturing neuraminic acid derivatives |
| 12/16/2009 | EP2132176A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors |
| 12/16/2009 | CN101602754A Flavanone derivatives, preparation method and use thereof |
| 12/16/2009 | CN100569769C Compounds with antibacterial activity |
| 12/10/2009 | WO2009147984A1 Dna encoding polypeptide involved in biosynthesis of herboxidiene |
| 12/10/2009 | WO2009147616A1 [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials |
| 12/10/2009 | WO2009116883A8 Process |
| 12/10/2009 | CA2725616A1 [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials |
| 12/09/2009 | EP2130822A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents |
| 12/09/2009 | EP2130541A2 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 12/09/2009 | EP2129670A2 Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor |
| 12/09/2009 | CN101600706A Akt活性抑制剂 Akt activity inhibitor |
| 12/09/2009 | CN101600697A New phenyl- (4-phenyl-pyrimidin-2-yl) - amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors |
| 12/08/2009 | US7629477 mitotic kinesins like KSP inhibitors; for treating cellular proliferative diseases; N-(3-Aminopropyl)-N [(R)-1-3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methyl-propyl]-4-methyl-benzamide |